MAC Clinical Research is delighted to announce that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved amendments to the Clinical Trial Application
Effective project management is vital to the success of a clinical trial, helping to ensure that studies are conducted smoothly, efficiently, and in line with
At the end of 2024, MAC Laboratory Services reached an exciting milestone: full accreditation under the Good Laboratory Practice (GLP) Monitoring Scheme. The impact of
As we wrap up 2024, it’s the perfect time to look back at a year filled with exciting advancements, initiatives and milestones. From groundbreaking studies
MAC Clinical Research is proud to announce the successful completion of the single ascending dose (SAD) phase of the first-in-human (FIH) clinical trial for KP405,
At MAC, patients and volunteers are more than participants – they are partners in everything we do. Their insights, experiences, and willingness to engage in
We are pleased to share a recent publication in conjunction with the UK Health Security Agency (UKHSA) and insights from MAC Clinical Research Statisticians Ellie
MAC Clinical Research’s Manchester site is an MHRA audited and accredited Phase I centre located within and supported by the Manchester University Foundation Trust, specialising
As well as working towards being a more sustainable company, there is a big drive for us to pass this ethos through our supply chain,
MAC Clinical Research and Kariya Pharmaceuticals are pleased to share the successful dosing of the first cohort in a phase 1 first-in-human (FIH) clinical trial
